Studies on head and neck squamous cell carcinoma showed that high expression of PHD2 was associated with an aggressive phenotype [37] and high tumor PHD2 levels in hepatocellular carcinoma (HCC) were associated with higher tumor stage, larger tumor size, and worse overall patient survival [38]. This evidence concerns the gene EGLN1 and neoplasm.